Cipla - Latest News on Cipla | Read Breaking News on Zee News

Cipla partners with Hetero to launch biosimilar anaemia drug

Last Updated: Thursday, June 19, 2014, 13:21

Pharma major Cipla on Thursday announced a collaboration with Hetero Drugs to launch a medication under the Actorise brand for treatment of anaemia caused due to chronic kidney disease.

Cipla makes user-friendly AIDS drug for African kids

Last Updated: Wednesday, June 26, 2013, 12:26

Indian drug major Cipla is working with a global health NGO to manufacture the first user-friendly pediatric HIV/AIDS drug targeted at millions of African children who are currently being forced to take medicine that is unpalatable - to say the least.

Cipla launches biosimilar for rheumatic disorders in India

Last Updated: Wednesday, April 17, 2013, 12:48

Drug major Cipla on Wednesday said it has launched biosimilar of Etanercept under the brand name `Etacept` used for treatment of rheumatic disorders in India.

India revokes patent on Merck & Co`s asthma drug

Last Updated: Tuesday, December 11, 2012, 22:36

Indian Patents Office has revoked a patent for an asthma drug held by US-based Merck & Co following a challenge from domestic pharma firm Cipla.

HC order against marketing of Cipla`s anti-cancer drug stayed

Last Updated: Thursday, November 08, 2012, 20:45

The Supreme Court today stayed for a month a Delhi High Court order restraining pharma major Cipla from marketing its anti-cancer drug "Sunitinib."

Cipla slashes cancer drug prices by up to 64%

Last Updated: Thursday, November 08, 2012, 18:10

Giving some relief to cancer patients, pharma major Cipla today slashed prices of its three generic cancer drugs by up to 64 per cent.

Cipla`s anti-malaria drug receives WHO pre-qualification

Last Updated: Thursday, October 04, 2012, 09:00

Drug firm Cipla today said an anti-malarial drug developed by Drugs for Neglected Diseases initiative (DNDi) has received pre-qualification from the World Health Organisation (WHO).

Cipla launches HIV/AIDS treatment kit at Rs 158

Last Updated: Tuesday, August 14, 2012, 19:30

Drug major Cipla today said it has launched `Qvir`, a four-drug kit priced at Rs 158 per kit to be used for treating HIV/AIDS.

First Prev 1 2 Next Last